Abstract
Heart failure is an increasing reason for hospitalization and the leading cause of death in patients with adult congenital heart disease (ACHD). Recently, the European Society of Cardiology and the American Heart Association published consensus documents on the management of chronic heart failure in ACHD patients. However, little data and/or guidelines are available for the management of (sub)acute heart failure. The ACHD population is heterogeneous by definition and often has complex underlying anatomy, which could pose a challenge to the physician confronted with the ACHD patient in (sub)acute heart failure. Recognizing the underlying anatomy and awareness of the possible complications related would result in better treatment, avoid unnecessary delays, and improve outcomes of the ACHD patient with (sub)acute heart failure. This review focuses on the management of (sub)acute heart failure in ACHD with specific attention to lesion-specific issues.
Similar content being viewed by others
References
Moons P, Bovijn L, Budts W, Belmans A, Gewillig M (2010) Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation 122(22):2264–2272. https://doi.org/10.1161/CIRCULATIONAHA.110.946343
Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, Somerville J, Williams RG, Webb GD (2001) Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol 37(5):1170–1175. https://doi.org/10.1016/S0735-1097(01)01272-4
Bolger AP, Gatzoulis MA (2004) Towards defining heart failure in adults with congenital heart disease. Int J Cardiol 97(Suppl 1):15–23. https://doi.org/10.1016/j.ijcard.2004.08.005
Diller GP, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, Li W, Babu-Narayan S, Wort SJ, Dimopoulos K, Gatzoulis MA. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation 2015
Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Sieswerda GT, Plokker HW, Grobbee DE, Mulder BJ (2010) The emerging burden of hospital admissions of adults with congenital heart disease. Heart 96(11):872–878. https://doi.org/10.1136/hrt.2009.185595
Mackie AS, Pilote L, Ionescu-Ittu R, Rahme E, Marelli AJ (2007) Health care resource utilization in adults with congenital heart disease. Am J Cardiol 99(6):839–843. https://doi.org/10.1016/j.amjcard.2006.10.054
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) Authors/Task Force M. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200. https://doi.org/10.1093/eurheartj/ehw128
Burchill LJ, Redington AN, Silversides CK, Ross HJ, Jimenez-Juan L, Mital S, Oechslin EN, Dragulescu A, Slorach C, Mertens L, Wald RM (2015) Renin-angiotensin-aldosterone system genotype and serum BNP in a contemporary cohort of adults late after Fontan palliation. Int J Cardiol 197:209–215. https://doi.org/10.1016/j.ijcard.2015.06.018
Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, Coats AJ, Anker SD, Gatzoulis MA (2002) Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 106(1):92–99. https://doi.org/10.1161/01.CIR.0000020009.30736.3F
Sharma R, Bolger AP, Li W, Davlouros PA, Volk HD, Poole-Wilson PA, Coats AJ, Gatzoulis MA, Anker SD (2003) Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol 92(2):188–193. https://doi.org/10.1016/S0002-9149(03)00536-8
Mou SS, Haudek SB, Lequier L, Pena O, Leonard S, Nikaidoh H, Giroir BP, Stromberg D (2002) Myocardial inflammatory activation in children with congenital heart disease. Crit Care Med 30(4):827–832. https://doi.org/10.1097/00003246-200204000-00018
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847
Budts W, Roos-Hesselink J, Radle-Hurst T, Eicken A, McDonagh TA, Lambrinou E, Crespo-Leiro MG, Walker F, Frogoudaki AA (2016) Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 37(18):1419–1427. https://doi.org/10.1093/eurheartj/ehv741
Welke KF, Morris CD, King E, Komanapalli C, Reller MD, Ungerleider RM (2007) Population-based perspective of long-term outcomes after surgical repair of partial atrioventricular septal defect. Ann Thorac Surg 84(2):624–628; discussion 628-9. https://doi.org/10.1016/j.athoracsur.2007.03.079
De Meester P, Buys R, Van De Bruaene A, Gabriels C, Voigt JU, Vanhees L, Herijgers P, Troost E, Budts W (2014) Functional and haemodynamic assessment of mild-to-moderate pulmonary valve stenosis at rest and during exercise. Heart 100(17):1354–1359. https://doi.org/10.1136/heartjnl-2014-305627
Voet A, Rega F, de Bruaene AV, Troost E, Gewillig M, Van Damme S, Budts W (2012) Long-term outcome after treatment of isolated pulmonary valve stenosis. Int J Cardiol 156(1):11–15. https://doi.org/10.1016/j.ijcard.2010.10.038
Kim HW, Seo DM, Shin HJ, Park JJ, Yoon TJ (2011) Long term results of right ventricular outflow tract reconstruction with homografts. Korean J Thorac Cardiovasc Surg 44(2):108–114. https://doi.org/10.5090/kjtcs.2011.44.2.108
Wood P (1958) The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J 2(5099):755–762. https://doi.org/10.1136/bmj.2.5099.755
Raymond RJ, Hinderliter AL, Willis PW, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B, Schwartz T, Koch G, Clayton LM, Jobsis MM, Crow JW, Long W (2002) Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 39(7):1214–1219. https://doi.org/10.1016/S0735-1097(02)01744-8
Diller GP, Dimopoulos K, Kafka H, Yen HS, Gatzoulis MA (2007) Model of chronic adaptation: right ventricular function in Eisenmenger syndrome. Eur Heart J Suppl 9(suppl_H):H54–H60. https://doi.org/10.1093/eurheartj/sum019
Diller GP, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, Harries C, Goktekin O, Gibbs JS, Gatzoulis MA (2006) Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J 27(14):1737–1742. https://doi.org/10.1093/eurheartj/ehl116
Cantor WJ, Harrison DA, Moussadji JS, Connelly MS, Webb GD, Liu P, McLaughlin PR, Siu SC (1999) Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol 84(6):677–681. https://doi.org/10.1016/S0002-9149(99)00415-4
Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G, Stone S (1998) Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 19(12):1845–1855. https://doi.org/10.1053/euhj.1998.1046
Van De Bruaene A, De Meester P, Voigt JU, Delcroix M, Pasquet A, De Backer J, De Pauw M, Naeije R, Vachiery JL, Paelinck B, Morissens M, Budts W (2012) Right ventricular function in patients with Eisenmenger syndrome. Am J Cardiol 109(8):1206–1211. https://doi.org/10.1016/j.amjcard.2011.12.003
Schuuring MJ, van Riel AC, Vis JC, Duffels MG, van Dijk AP (2015) de Bruin-Bon RH, Zwinderman AH, Mulder BJ, Bouma BJ. New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: midterm outcome of a prospective study. Int J Cardiol 181:270–276. https://doi.org/10.1016/j.ijcard.2014.11.222
Gewillig M, Brown SC, Eyskens B, Heying R, Ganame J, Budts W, La Gerche A, Gorenflo M (2010) The Fontan circulation: who controls cardiac output? Interact Cardiovasc Thorac Surg 10(3):428–433. https://doi.org/10.1510/icvts.2009.218594
Gewillig M (2005) Ventricular dysfunction of the functionally univentricular heart: management and outcomes. Cardiol Young 15(Suppl 3):31–34. https://doi.org/10.1017/S1047951105001605
Cordina R, von Klemperer K, Kempny A, West C, Senior R, Celermajer DS, Gatzoulis MA, Babu-Narayan SV, Li W (2017) Echocardiographic predictors of mortality in adults with a Fontan circulation. JACC Cardiovasc Imaging 10(2):212–213. https://doi.org/10.1016/j.jcmg.2016.03.006
Cheung YF, Penny DJ, Redington AN (2000) Serial assessment of left ventricular diastolic function after Fontan procedure. Heart 83(4):420–424. https://doi.org/10.1136/heart.83.4.420
Gewillig MH, Lundstrom UR, Deanfield JE, Bull C, Franklin RC, Graham TP Jr, Wyse RK (1990) Impact of Fontan operation on left ventricular size and contractility in tricuspid atresia. Circulation 81(1):118–127. https://doi.org/10.1161/01.CIR.81.1.118
Cheung MM, Smallhorn JF, McCrindle BW, Van Arsdell GS, Redington AN (2005) Non-invasive assessment of ventricular force-frequency relations in the univentricular circulation by tissue Doppler echocardiography: a novel method of assessing myocardial performance in congenital heart disease. Heart 91(10):1338–1342. https://doi.org/10.1136/hrt.2004.048207
Gaynor JW, Bridges ND, Cohen MI, Mahle WT, Decampli WM, Steven JM, Nicolson SC, Spray TL (2002) Predictors of outcome after the Fontan operation: is hypoplastic left heart syndrome still a risk factor? J Thorac Cardiovasc Surg 123(2):237–245. https://doi.org/10.1067/mtc.2002.119337
Gentles TL, Gauvreau K, Mayer JE Jr, Fishberger SB, Burnett J, Colan SD, Newburger JW, Wernovsky G (1997) Functional outcome after the Fontan operation: factors influencing late morbidity. J Thorac Cardiovasc Surg 114(3):392–403; discussion 404-5. https://doi.org/10.1016/S0022-5223(97)70184-3
Ho SY (2009) Anatomy and myoarchitecture of the left ventricular wall in normal and in disease. Eur J Echocardiogr 10:iii3–iii7
Roche SL, Redington AN (2013) The failing right ventricle in congenital heart disease. Can J Cardiol 29(7):768–778. https://doi.org/10.1016/j.cjca.2013.04.018
Graham TP Jr, Bernard YD, Mellen BG, Celermajer D, Baumgartner H, Cetta F, Connolly HM, Davidson WR, Dellborg M, Foster E, Gersony WM, Gessner IH, Hurwitz RA, Kaemmerer H, Kugler JD, Murphy DJ, Noonan JA, Morris C, Perloff JK, Sanders SP, Sutherland JL (2000) Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol 36:255–261
Dos L, Teruel L, Ferreira IJ, Rodriguez-Larrea J, Miro L, Girona J, Albert DC, Goncalves A, Murtra M, Casaldaliga J (2005) Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart 91(5):652–656. https://doi.org/10.1136/hrt.2003.029769
Moons P, Gewillig M, Sluysmans T, Verhaaren H, Viart P, Massin M, Suys B, Budts W, Pasquet A, De Wolf D, Vliers A (2004) Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in Belgium. Heart 90(3):307–313. https://doi.org/10.1136/hrt.2002.007138
Helsen F, De Meester P, Van Keer J, Gabriels C, Van De Bruaene A, Herijgers P, Rega F, Meyns B, Gewillig M, Troost E, Budts W (2015) Pulmonary outflow obstruction protects against heart failure in adults with congenitally corrected transposition of the great arteries. Int J Cardiol 196:1–6. https://doi.org/10.1016/j.ijcard.2015.05.142
Allwork SP, Bentall HH, Becker AE, Cameron H, Gerlis LM, Wilkinson JL, Anderson RH (1976) Congenitally corrected transposition of the great arteries: morphologic study of 32 cases. Am J Cardiol 38(7):910–923. https://doi.org/10.1016/0002-9149(76)90804-3
Pettersen E, Helle-Valle T, Edvardsen T, Lindberg H, Smith HJ, Smevik B, Smiseth OA, Andersen K (2007) Contraction pattern of the systemic right ventricle shift from longitudinal to circumferential shortening and absent global ventricular torsion. J Am Coll Cardiol 49(25):2450–2456. https://doi.org/10.1016/j.jacc.2007.02.062
Derrick GP, Narang I, White PA, Kelleher A, Bush A, Penny DJ, Redington AN (2000) Failure of stroke volume augmentation during exercise and dobutamine stress is unrelated to load-independent indexes of right ventricular performance after the Mustard operation. Circulation 102(19 Suppl 3):III154–III159
van der Bom T, Winter MM, Bouma BJ, Groenink M, Vliegen HW, Pieper PG, van Dijk AP, Sieswerda GT, Roos-Hesselink JW, Zwinderman AH, Mulder BJ (2013) Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation 127(3):322–330. https://doi.org/10.1161/CIRCULATIONAHA.112.135392
Dore A, Houde C, Chan KL, Ducharme A, Khairy P, Juneau M, Marcotte F, Mercier LA (2005) Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation 112(16):2411–2416. https://doi.org/10.1161/CIRCULATIONAHA.105.543470
Therrien J, Provost Y, Harrison J, Connelly M, Kaemmerer H, Webb GD (2008) Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study. Int J Cardiol 129(2):187–192. https://doi.org/10.1016/j.ijcard.2008.04.056
Murray CD (1926) The physiological principle of minimum work: I. The vascular system and the cost of blood volume. Proc Natl Acad Sci U S A 12(3):207–214. https://doi.org/10.1073/pnas.12.3.207
Glenny RW (2011) Emergence of matched airway and vascular trees from fractal rules. J Appl Physiol 110(4):1119–1129. https://doi.org/10.1152/japplphysiol.01293.2010
Duffels MG, Engelfriet PM, Berger RM, van Loon RL, Hoendermis E, Vriend JW, van der Velde ET, Bresser P, Mulder BJ (2007) Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol 120(2):198–204. https://doi.org/10.1016/j.ijcard.2006.09.017
Engelfriet PM, Duffels MG, Moller T, Boersma E, Tijssen JG, Thaulow E, Gatzoulis MA, Mulder BJ (2007) Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart 93(6):682–687. https://doi.org/10.1136/hrt.2006.098848
Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, Vliegen HW, Grobbee DE, Mulder BJ (2010) Mortality in adult congenital heart disease. Eur Heart J 31(10):1220–1229. https://doi.org/10.1093/eurheartj/ehq032
Egbe AC, Connolly HM, Niaz T, Yogeswaran V, Taggart NW, Qureshi MY, Poterucha JT, Khan AR, Driscoll DJ (2017) Prevalence and outcome of thrombotic and embolic complications in adults after Fontan operation. Am Heart J 183:10–17. https://doi.org/10.1016/j.ahj.2016.09.014
Egbe AC, Connolly HM, McLeod CJ, Ammash NM, Niaz T, Yogeswaran V, Poterucha JT, Qureshi MY, Driscoll DJ (2016) Thrombotic and embolic complications associated with atrial arrhythmia after Fontan operation: role of prophylactic therapy. J Am Coll Cardiol 68(12):1312–1319. https://doi.org/10.1016/j.jacc.2016.06.056
Silversides CK, Granton JT, Konen E, Hart MA, Webb GD, Therrien J (2003) Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 42(11):1982–1987. https://doi.org/10.1016/j.jacc.2003.07.022
Broberg CS, Ujita M, Prasad S, Li W, Rubens M, Bax BE, Davidson SJ, Bouzas B, Gibbs JS, Burman J, Gatzoulis MA (2007) Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol 50(7):634–642. https://doi.org/10.1016/j.jacc.2007.04.056
Van De Bruaene A, La Gerche A, Prior DL, Voigt J-U, Delcroix M, Budts W. Pulmonary vascular resistance as assessed by bicycle stress echocardiography in patients with ASD type secundum. Circulation: Cardiovascular Imaging
Inglessis I, Landzberg MJ (2007) Interventional catheterization in adult congenital heart disease. Circulation 115(12):1622–1633. https://doi.org/10.1161/CIRCULATIONAHA.105.592428
Srivastava D, Preminger T, Lock JE, Mandell V, Keane JF, Mayer JE Jr, Kozakewich H, Spevak PJ (1995) Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Circulation 92(5):1217–1222. https://doi.org/10.1161/01.CIR.92.5.1217
Kuijpers JM, Koolbergen DR, Groenink M, Peels KC, Reichert CL, Post MC, Bosker HA, Wajon EM, Zwinderman AH, Mulder BJ, Bouma BJ. Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J 38(26):2048–2056. https://doi.org/10.1093/eurheartj/ehw591
Van Dijck I, Budts W, Cools B, Eyskens B, Boshoff DE, Heying R, Frerich S, Vanagt WY, Troost E, Gewillig M (2015) Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart 101(10):788–793. https://doi.org/10.1136/heartjnl-2014-306761
Yoshinaga M, Niwa K, Niwa A, Ishiwada N, Takahashi H, Echigo S, Nakazawa M (2008) Japanese Society of Pediatric C, Cardiac S. Risk factors for in-hospital mortality during infective endocarditis in patients with congenital heart disease. Am J Cardiol 101(1):114–118. https://doi.org/10.1016/j.amjcard.2007.07.054
Schmitt HJ, Schuetz WH, Proeschel PA, Jaklin C (1993) Accuracy of pulse oximetry in children with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth 7(1):61–65. https://doi.org/10.1016/1053-0770(93)90120-A
Baggen VJ, van den Bosch AE, Eindhoven JA, Schut AW, Cuypers JA, Witsenburg M, de Waart M, van Schaik RH, Zijlstra F, Boersma E, Roos-Hesselink JW (2017) Prognostic value of N-terminal pro-B-type natriuretic peptide, troponin-T, and growth-differentiation factor 15 in adult congenital heart disease. Circulation 135(3):264–279. https://doi.org/10.1161/CIRCULATIONAHA.116.023255
Giannakoulas G, Dimopoulos K, Bolger AP, Tay EL, Inuzuka R, Bedard E, Davos C, Swan L, Gatzoulis MA (2010) Usefulness of natriuretic peptide levels to predict mortality in adults with congenital heart disease. Am J Cardiol 105(6):869–873. https://doi.org/10.1016/j.amjcard.2009.11.041
Van De Bruaene A, Hickey EJ, Kovacs AH, Crean AM, Wald RM, Silversides CK, Redington AN, Ross HJ, Alba AC, Billia F, Nair K, Benson L, Horlick E, Osten M, Colman J, Heggie J, Oechslin EN, Roche SL (2017) Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure.Int J Cardiol. https://doi.org/10.1016/j.ijcard.2017.10.086.
Gewillig M, Wyse RK, de Leval MR, Deanfield JE (1992) Early and late arrhythmias after the Fontan operation: predisposing factors and clinical consequences. Br Heart J 67(1):72–79. https://doi.org/10.1136/hrt.67.1.72
Reich JD, Auld D, Hulse E, Sullivan K, Campbell R (1998) The pediatric radiofrequency ablation registry’s experience with Ebstein’s anomaly. Pediatric Electrophysiology Society. J Cardiovasc Electrophysiol 9(12):1370–1377. https://doi.org/10.1111/j.1540-8167.1998.tb00113.x
Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN (2000) Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 356(9234):975–981. https://doi.org/10.1016/S0140-6736(00)02714-8
Kammeraad JA, van Deurzen CH, Sreeram N, Bink-Boelkens MT, Ottenkamp J, Helbing WA, Lam J, Sobotka-Plojhar MA, Daniels O, Balaji S (2004) Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol 44(5):1095–1102. https://doi.org/10.1016/j.jacc.2004.05.073
Eyskens B, Mertens L, Moerman P, Ector H, Daenen W, Gewillig M (1997) Cardiac strangulation, a rare complication of epicardial pacemaker leads during growth. Heart 77(3):288–289. https://doi.org/10.1136/hrt.77.3.288
Frescura C, Basso C, Thiene G, Corrado D, Pennelli T, Angelini A, Daliento L (1998) Anomalous origin of coronary arteries and risk of sudden death: a study based on an autopsy population of congenital heart disease. Hum Pathol 29(7):689–695. https://doi.org/10.1016/S0046-8177(98)90277-5
Taylor AJ, Rogan KM, Virmani R (1992) Sudden cardiac death associated with isolated congenital coronary artery anomalies. J Am Coll Cardiol 20(3):640–647. https://doi.org/10.1016/0735-1097(92)90019-J
Raisky O, Bergoend E, Agnoletti G, Ou P, Bonnet D, Sidi D, Vouhe PR (2007) Late coronary artery lesions after neonatal arterial switch operation: results of surgical coronary revascularization. Eur J Cardiothorac Surg 31(5):894–898. https://doi.org/10.1016/j.ejcts.2007.02.003
Pillutla P, Shetty KD, Foster E (2009) Mortality associated with adult congenital heart disease: trends in the US population from 1979 to 2005. Am Heart J 158(5):874–879. https://doi.org/10.1016/j.ahj.2009.08.014
Bhatt AB, Foster E, Kuehl K, Alpert J, Brabeck S, Crumb S, Davidson WR Jr, Earing MG, Ghoshhajra BB, Karamlou T, Mital S, Ting J, Tseng ZH (2015) Congenital heart disease in the older adult: a scientific statement from the American Heart Association. Circulation 131(21):1884–1931. https://doi.org/10.1161/CIR.0000000000000204
Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ (2010) Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care 14(5):R169. https://doi.org/10.1186/cc9264
Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Ellims AH, Taylor AJ, Meredith IT, Kaye DM (2015) Air versus oxygen in ST-segment-elevation myocardial infarction. Circulation 131(24):2143–2150. https://doi.org/10.1161/CIRCULATIONAHA.114.014494
Park JH, Balmain S, Berry C, Morton JJ, McMurray JJ (2010) Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart 96(7):533–538. https://doi.org/10.1136/hrt.2009.175257
Delcroix M, Naeije R (2010) Optimising the management of pulmonary arterial hypertension patients: emergency treatments. Eur Respir Rev 19(117):204–211. https://doi.org/10.1183/09059180.00004910
Mullens W, Abrahams Z, Francis GS, Skouri HN, Starling RC, Young JB, Taylor DO, Tang WH (2008) Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol 52(3):200–207. https://doi.org/10.1016/j.jacc.2008.02.083
Apitz C, Honjo O, Friedberg MK, Assad RS, Van Arsdell G, Humpl T, Redington AN (2012) Beneficial effects of vasopressors on right ventricular function in experimental acute right ventricular failure in a rabbit model. Thorac Cardiovasc Surg 60(1):17–23. https://doi.org/10.1055/s-0031-1298058
Apitz C, Honjo O, Humpl T, Li J, Assad RS, Cho MY, Hong J, Friedberg MK, Redington AN (2012) Biventricular structural and functional responses to aortic constriction in a rabbit model of chronic right ventricular pressure overload. J Thorac Cardiovasc Surg 144(6):1494–1501. https://doi.org/10.1016/j.jtcvs.2012.06.027
Hyldebrandt JA, Agger P, Siven E, Wemmelund KB, Heiberg J, Frederiksen CA, Ravn HB (2015) Effects of milrinone and epinephrine or dopamine on biventricular function and hemodynamics in right heart failure after pulmonary regurgitation. Am J Physiol Heart Circ Physiol 309(5):H860–H866. https://doi.org/10.1152/ajpheart.00384.2015
Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey JM, Akbary A, Kocsis JF, Kaczmarek R, Spray TL, Wessel DL (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107(7):996–1002. https://doi.org/10.1161/01.CIR.0000051365.81920.28
Smith AH, Owen J, Borgman KY, Fish FA, Kannankeril PJ (2011) Relation of milrinone after surgery for congenital heart disease to significant postoperative tachyarrhythmias. Am J Cardiol 108(11):1620–1624. https://doi.org/10.1016/j.amjcard.2011.07.023
Kerbaul F, Rondelet B, Motte S, Fesler P, Hubloue I, Ewalenko P, Naeije R, Brimioulle S (2004) Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure. Crit Care Med 32(4):1035–1040. https://doi.org/10.1097/01.CCM.0000120052.77953.07
Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L, Steering C (2002) Investigators of the Levosimendan Infusion versus Dobutamine S. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360(9328):196–202. https://doi.org/10.1016/S0140-6736(02)09455-2
Ricci Z, Garisto C, Favia I, Vitale V, Di Chiara L, Cogo PE (2012) Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial. Intensive Care Med 38(7):1198–1204. https://doi.org/10.1007/s00134-012-2564-6
Bhorade S, Christenson J, O'Connor M, Lavoie A, Pohlman A, Hall JB (1999) Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 159(2):571–579. https://doi.org/10.1164/ajrccm.159.2.9804127
Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, Niedermeyer J, Fabel H, Seeger W (2000) A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol 35(1):176–182. https://doi.org/10.1016/S0735-1097(99)00494-5
Van De Bruaene A, La Gerche A, Claessen G, De Meester P, Devroe S, Gillijns H, Bogaert J, Claus P, Heidbuchel H, Gewillig M, Budts W (2014) Sildenafil improves exercise hemodynamics in Fontan patients. Circ Cardiovasc Imaging 7(2):265–273. https://doi.org/10.1161/CIRCIMAGING.113.001243
Allan CK (2011) Intensive care of the adult patient with congenital heart disease. Prog Cardiovasc Dis 53(4):274–280. https://doi.org/10.1016/j.pcad.2010.11.002
Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli MF, Poole-Wilson PA, Best N, Francis DP, Gatzoulis MA (2008) Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 117(18):2320–2328. https://doi.org/10.1161/CIRCULATIONAHA.107.734921
Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, Paganini E, Tang WH (2008) Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51(3):300–306. https://doi.org/10.1016/j.jacc.2007.09.043
Tay EL, Peset A, Papaphylactou M, Inuzuka R, Alonso-Gonzalez R, Giannakoulas G, Tzifa A, Goletto S, Broberg C, Dimopoulos K, Gatzoulis MA (2011) Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. Int J Cardiol 151(3):307–312. https://doi.org/10.1016/j.ijcard.2010.05.066
Oechslin E (2004) Hematological management of the cyanotic adult with congenital heart disease. Int J Cardiol 97(Suppl 1):109–115. https://doi.org/10.1016/j.ijcard.2004.08.015
Van De Bruaene A DM, Pasquet A, De Backer J, De Pauw M, Naeije R, Vachiéry JL, Paelinck B, Morissens M, Budts W. Iron deficiency is associated with adverse outcome in Eisenmenger patients. Eur Heart J 2011; Accepted for publication
Tomkiewicz-Pajak L, Hoffman P, Trojnarska O, Lipczynska M, Podolec P, Undas A (2014) Abnormalities in blood coagulation, fibrinolysis, and platelet activation in adult patients after the Fontan procedure. J Thorac Cardiovasc Surg 147(4):1284–1290. https://doi.org/10.1016/j.jtcvs.2013.06.011
Goldberg DJ, Surrey LF, Glatz AC, Dodds K, O'Byrne ML, Lin HC, Fogel M, Rome JJ, Rand EB, Russo P, Rychik J, Hepatic Fibrosis I (2017) Universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc 6(5):e004809. https://doi.org/10.1161/JAHA.116.004809
Kiesewetter CH, Sheron N, Vettukattill JJ, Hacking N, Stedman B, Millward-Sadler H, Haw M, Cope R, Salmon AP, Sivaprakasam MC, Kendall T, Keeton BR, Iredale JP, Veldtman GR (2007) Hepatic changes in the failing Fontan circulation. Heart 93(5):579–584. https://doi.org/10.1136/hrt.2006.094516
Rychik J (2016) The relentless effects of the Fontan paradox. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 19(1):37–43. https://doi.org/10.1053/j.pcsu.2015.11.006
Rychik J (2007) Protein-losing enteropathy after Fontan operation. Congenit Heart Dis 2(5):288–300. https://doi.org/10.1111/j.1747-0803.2007.00116.x
Satomi G, Yasukochi S, Harada Y, Takeuchi M (1996) Effect of percutaneous fenestration of the atrial septum on protein-losing enteropathy after the Fontan operation. Heart 76(1):90–91. https://doi.org/10.1136/hrt.76.1.90-b
Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK (2009) INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 28(6):535–541. https://doi.org/10.1016/j.healun.2009.02.015
Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, Kern M, Garratt KN, Goldstein JA, Dimas V, Tu T (2015) Society for Cardiovascular A, Interventions, Heart Failure Society of A, Society for Thoracic S, American Heart A, American College of C. 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention). J Card Fail 21(6):499–518. https://doi.org/10.1016/j.cardfail.2015.03.002
Kawashima D, Gojo S, Nishimura T, Itoda Y, Kitahori K, Motomura N, Morota T, Murakami A, Takamoto S, Kyo S, Ono M (2011) Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J 57(3):169–176. https://doi.org/10.1097/MAT.0b013e31820e121c
Menachem JN, Swaminathan AC, Bashore TM, Ward CC, Rogers JG, Milano CA, Patel CB (2015) Initial experience of left ventricular assist device support for adult patients with transposition of the great vessels. Congenit Heart Dis 10(5):382–386. https://doi.org/10.1111/chd.12264
Stewart AS, Gorman RC, Pocchetino A, Rosengard BR, Acker MA (2002) Left ventricular assist device for right side assistance in patients with transposition. Ann Thorac Surg 74(3):912–914. https://doi.org/10.1016/S0003-4975(02)03671-8
Joyce DL, Crow SS, John R, St Louis JD, Braunlin EA, Pyles LA, Kofflin P, Joyce LD (2010) Mechanical circulatory support in patients with heart failure secondary to transposition of the great arteries. J Heart Lung Transplant 29(11):1302–1305. https://doi.org/10.1016/j.healun.2010.05.030
Shah NR, Lam WW, Rodriguez FH 3rd, Ermis PR, Simpson L, Frazier OH, Franklin WJ, Parekh DR (2013) Clinical outcomes after ventricular assist device implantation in adults with complex congenital heart disease. J Heart Lung Transplant 32(6):615–620. https://doi.org/10.1016/j.healun.2013.03.003
Agusala K, Bogaev R, Frazier OH, Franklin WJ (2010) Ventricular assist device placement in an adult with D-transposition of the great arteries with prior Mustard operation. Congenit Heart Dis 5(6):635–637. https://doi.org/10.1111/j.1747-0803.2010.00408.x
VanderPluym C, Urschel S, Buchholz H (2013) Advanced therapies for congenital heart disease: ventricular assist devices and heart transplantation. Can J Cardiol 29(7):796–802. https://doi.org/10.1016/j.cjca.2013.02.008
Kirk R, Dipchand AI, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbles F, Rahmel AO, Stehlik J, Hertz MI (2012) International Society for H, Lung T. The Registry of the International Society for Heart and Lung Transplantation: fifteenth pediatric heart transplantation report—2012. J Heart Lung Transplant 31(10):1065–1072. https://doi.org/10.1016/j.healun.2012.08.001
O'Connor MJ, Menteer J, Chrisant MR, Monos D, Lind C, Levine S, Gaynor JW, Hanna BD, Paridon SM, Ravishankar C, Kaufman BD (2010) Ventricular assist device-associated anti-human leukocyte antigen antibody sensitization in pediatric patients bridged to heart transplantation. J Heart Lung Transplant 29(1):109–116. https://doi.org/10.1016/j.healun.2009.08.028
Yang J, Schall C, Smith D, Kreuser L, Zamberlan M, King K, Gajarski R (2009) HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex. J Heart Lung Transplant 28(2):123–129. https://doi.org/10.1016/j.healun.2008.11.908
Lewis M, Ginns J, Schulze C, Lippel M, Chai P, Bacha E, Mancini D, Rosenbaum M, Farr M. Outcomes of adult patients with congenital heart disease after heart transplantation: impact of disease type, previous thoracic surgeries, and bystander organ dysfunction. J Card Fail 22(7):578–82. https://doi.org/10.1016/j.cardfail.2015.09.002
Berg CJ, Bauer BS, Hageman A, Aboulhosn JA, Reardon LC (2017) Mortality risk stratification in Fontan patients who underwent heart transplantation. Am J Cardiol 119(10):1675–1679. https://doi.org/10.1016/j.amjcard.2017.02.005
Funding
Alexander Van De Bruaene is supported by a grant of the Frans van de Werf Fund for Clinical Cardiovascular Research and the Research Foundation Flanders (FWO).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Alexander Van De Bruaene is supported by a grant of the Frans van de Werf Fund for Clinical Cardiovascular Research and the Research Foundation Flanders (FWO).
Rights and permissions
About this article
Cite this article
Van De Bruaene, A., Meier, L., Droogne, W. et al. Management of acute heart failure in adult patients with congenital heart disease. Heart Fail Rev 23, 1–14 (2018). https://doi.org/10.1007/s10741-017-9664-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10741-017-9664-x